Your browser doesn't support javascript.
loading
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.
Abou Khouzam, Raefa; Janji, Bassam; Thiery, Jerome; Zaarour, Rania Faouzi; Chamseddine, Ali N; Mayr, Hemma; Savagner, Pierre; Kieda, Claudine; Gad, Sophie; Buart, Stéphanie; Lehn, Jean-Marie; Limani, Perparim; Chouaib, Salem.
Afiliação
  • Abou Khouzam R; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. Electronic address: dr.raefa@gmu.ac.ae.
  • Janji B; Department of Cancer Research, Luxembourg Institute of Health, Tumor Immunotherapy and Microenvironment (TIME) Group, 6A, rue Nicolas-Ernest Barblé, L-1210 Luxembourg city, Luxembourg. Electronic address: Bassam.Janji@lih.lu.
  • Thiery J; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France. Electronic address: Jerome.thiery@gustaveroussy.fr.
  • Zaarour RF; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. Electronic address: dr.rania@gmu.ac.ae.
  • Chamseddine AN; Gastroenterology Department, Cochin University Hospital, Université de Paris, APHP, Paris, France; Ambroise Paré - Hartmann Private Hospital Group, Oncology Unit, Neuilly-sur-Seine, France. Electronic address: dr.achamseddine@gmail.com.
  • Mayr H; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland; Department of Surgery & Transplantation, University and University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. Electronic address: hemma.Mayr@usz.ch.
  • Savagner P; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France. Electronic address: pierre.savagner@gustaveroussy.fr.
  • Kieda C; Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland; Centre for Molecular Biophysics, UPR 4301 CNRS, 45071 Orleans, France; Centre of Postgraduate Medical Education, 01-004 Warsaw, Poland. Electronic address: cl
  • Gad S; Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres University (PSL), 75014 Paris, France; UMR CNRS 9019, Genome Integrity and Cancers, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France. Electronic address: sophie.gad@gustaveroussy.fr.
  • Buart S; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France. Electronic address: stephanie.buart@gustaveroussy.fr.
  • Lehn JM; Institut de Science et d'Ingénierie Supramoléculaires (ISIS), Université de Strasbourg, 8 allée Gaspard Monge, Strasbourg, France. Electronic address: lehn@unistra.fr.
  • Limani P; Swiss Hepato-Pancreato-Biliary (HPB) and Transplantation Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland; Department of Surgery & Transplantation, University and University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland. Electronic address: Perparim.Limani@usz.c
  • Chouaib S; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, 94805 Villejuif, France. Electronic address: salem.chouaib@gmu.
Semin Cancer Biol ; 97: 104-123, 2023 12.
Article em En | MEDLINE | ID: mdl-38029865

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article